Study of Pulse Pressure During Tilttable and Erigo® in Adult Patients With Acquired Brain Injury

NCT ID: NCT02700399

Last Updated: 2016-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if the pulse pressure changes are different whether patients are training in a traditional tilt table as compared to a robotic assisted tilt table, which induces leg movement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial takes place in a non private hospital in Denmark. Patients are recruited from two wards treating patients with severe brain injury, and all patients admitted in the study period are considered in regards to inclusion or exclusion. Patients are included via closest relatives accept, and the patients GP(General Practitioner). Any adverse effect or event will be reported to the local ethics committee. All data will be collected simultaneously with the interventions. Some data will be directly recorded via monitor output, and some data will be directly inputted in Epidata, while trial takes place.

Sample size has been calculated to be between 10 and 60 individuals depending on the actual difference. Beyond 60 included individuals the clinical relevance of a statistical significant result is no longer apparent. If any individual variables are noncomplete, an analysis of the subjects with missing data, will be undertaken.

The statistical analyses planned follows the general crossover design using an approach considering 2 treatment and 2 periods. Patients are cluster randomized in clusters of 4, to be treated with one or the other intervention first.

Intervention A:

Traditional tilt table. measurements at 0 degrees 30 deg. 60. deg. and at return to 0 deg.

Intervention B:

Erigo® tilttable, with measurements as in intervention A. During the intervention the step frequency of the Erigo® i set at 48 steps/min.

Between the two periods a wash out period of at least ½ hour and maximum 2 hours are planned.

Primary outcome is derived from noninvasive BP measurements.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Injuries Hypotension, Orthostatic Syncope

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erigo® First

Erigo® 0 - 60 degrees - Wash out period (min 30 minutes, max 120 minutes) - Traditional Tilt table 0 - 60 degrees

Step frequency on Erigo® = 48

Group Type OTHER

Erigo® Hocoma

Intervention Type DEVICE

Robotics assisted tilt table, without functional electrical stimulation

Traditional tilt table from Rehab-Care

Intervention Type DEVICE

Traditional tilt table

Traditional first

Traditional Tilt table 0 - 60 degrees - Wash out period (min 30 minutes, max 120 minutes) - Erigo® 0 - 60 degrees

Step frequency on Erigo® = 48

Group Type OTHER

Erigo® Hocoma

Intervention Type DEVICE

Robotics assisted tilt table, without functional electrical stimulation

Traditional tilt table from Rehab-Care

Intervention Type DEVICE

Traditional tilt table

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erigo® Hocoma

Robotics assisted tilt table, without functional electrical stimulation

Intervention Type DEVICE

Traditional tilt table from Rehab-Care

Traditional tilt table

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Already being treated with traditional tilttable and must be able to benefit from Erigo® treatment from a clinicians view
* Acquired brain injury as primary diagnose
* Must have Rancho Los Amigo Scale score of minimum 1 to maximum 6 on the day of inclusion

Exclusion Criteria

* Not on mechanical ventilation
* New cerebral, cardiological or other medical problems/emergencies between the 2 interventions
* Change in cardiac medications between interventions
* Patient must not have independent gait function immediately before trial
* must not have EFA(Early Functional abilities) part score \> 4 in the section "Standing", assessed by the treating physiotherapist.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Regionshospitalet Hammel Neurocenter

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jørgen F Nielsen, Prof.MD DMSc

Role: STUDY_DIRECTOR

Regionshospitalet Hammel Neurocenter

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Regionshospitalet Hammel Neurocenter

Hammel, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SSK01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Reaching in Stroke 3rd Phase
NCT02912923 COMPLETED NA